nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM1—Amine ligand-binding receptors—HRH3—narcolepsy	0.0275	0.0275	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HRH3—narcolepsy	0.0274	0.0274	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—P2RY11—narcolepsy	0.0257	0.0257	CbGpPWpGaD
Cevimeline—CHRM1—Monoamine GPCRs—HTR2A—narcolepsy	0.0163	0.0163	CbGpPWpGaD
Cevimeline—CHRM3—Monoamine GPCRs—HTR2A—narcolepsy	0.0163	0.0163	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HCRTR2—narcolepsy	0.015	0.015	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HCRTR1—narcolepsy	0.015	0.015	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HCRTR2—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HCRTR1—narcolepsy	0.0149	0.0149	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—P2RY11—narcolepsy	0.0145	0.0145	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—P2RY11—narcolepsy	0.0144	0.0144	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—HCRTR2—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—HCRTR1—narcolepsy	0.0141	0.0141	CbGpPWpGaD
Cevimeline—CHRM1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Cevimeline—CHRM3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0137	0.0137	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.0134	0.0134	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0129	0.0129	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CHKB—narcolepsy	0.0125	0.0125	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HCRT—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HCRT—narcolepsy	0.0123	0.0123	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0116	0.0116	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0115	0.0115	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0112	0.0112	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0111	0.0111	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.011	0.011	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.011	0.011	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00992	0.00992	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00992	0.00992	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00989	0.00989	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00989	0.00989	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00958	0.00958	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00955	0.00955	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—TRH—narcolepsy	0.00932	0.00932	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—TRH—narcolepsy	0.00929	0.00929	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—CPT1B—narcolepsy	0.00847	0.00847	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00834	0.00834	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00831	0.00831	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00814	0.00814	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00812	0.00812	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HCRTR2—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00755	0.00755	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00753	0.00753	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00753	0.00753	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00729	0.00729	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00727	0.00727	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00726	0.00726	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00724	0.00724	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00723	0.00723	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00677	0.00677	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00677	0.00677	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00675	0.00675	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00675	0.00675	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00639	0.00639	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00632	0.00632	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.0063	0.0063	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.0062	0.0062	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00618	0.00618	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00617	0.00617	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00615	0.00615	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00606	0.00606	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00606	0.00606	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00604	0.00604	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00553	0.00553	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00551	0.00551	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00541	0.00541	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.0054	0.0054	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.0047	0.0047	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00469	0.00469	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00448	0.00448	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00447	0.00447	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00447	0.00447	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00427	0.00427	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00427	0.00427	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00425	0.00425	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00425	0.00425	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00412	0.00412	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00411	0.00411	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00411	0.00411	CbGpPWpGaD
Cevimeline—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00407	0.00407	CbGpPWpGaD
Cevimeline—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00406	0.00406	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00388	0.00388	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00388	0.00388	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00386	0.00386	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00386	0.00386	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00374	0.00374	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.00373	0.00373	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00364	0.00364	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00363	0.00363	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00351	0.00351	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00349	0.00349	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00342	0.00342	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.0034	0.0034	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00318	0.00318	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00317	0.00317	CbGpPWpGaD
Cevimeline—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00315	0.00315	CbGpPWpGaD
Cevimeline—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00314	0.00314	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00312	0.00312	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00311	0.00311	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CHKB—narcolepsy	0.0031	0.0031	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00284	0.00284	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00283	0.00283	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.0027	0.0027	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00266	0.00266	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00265	0.00265	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.00241	0.00241	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.0024	0.0024	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.00229	0.00229	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00228	0.00228	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.00221	0.00221	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.00212	0.00212	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00211	0.00211	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CPT1B—narcolepsy	0.00211	0.00211	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.00205	0.00205	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.00193	0.00193	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.00192	0.00192	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CHKB—narcolepsy	0.00185	0.00185	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.00175	0.00175	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PENK—narcolepsy	0.00168	0.00168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PENK—narcolepsy	0.00167	0.00167	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TRH—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TRH—narcolepsy	0.00142	0.00142	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CPT1B—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CHKB—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.00116	0.00116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPS—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.00104	0.00104	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPS—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.00103	0.00103	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000824	0.000824	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000623	0.000623	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.000621	0.000621	CbGpPWpGaD
